Additional information “ Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant ” was published in JAMA Network Open on March 11. The study was funded by the Department of ...

More than 200 employees participated in the CUIMC Team Relay Marathon at The Armory last week. At the relay race event, which also included teams outside of Columbia, teams of two to eight runners ...

The Vagelos Institute’s Biomedical Research Education (VIBRE) PhD Programs will launch in the Fall of 2026, unifying previous doctoral programs at the Vagelos College of Physicians and Surgeons. VIBRE ...

Each autumn, fourth-year medical students at the Vagelos College of Physicians and Surgeons (VP&S) embark on a ritual that is equal parts life-changing and career-defining—the residency interview ...

As part of our ongoing commitment to support survivors, Columbia has worked with RAINN, the nation's largest anti-sexual violence nonprofit, to establish a free, confidential, 24/7 helpline for ...

Now a new study from Columbia researchers suggests that metformin is indeed a promising drug that could prevent the progression of prostate cancer, but only for tumors with low levels of NKX3.1, which ...

Legend has it that Marie Antoinette’s hair turned gray overnight just before her beheading in 1791. Though the legend is inaccurate—hair that has already grown out of the follicle does not change ...

Within 3 weeks, mice that received topical ruxolitinib or tofacitinib had regrown nearly all their hair (right photo; drug was applied only to the right side of the mouse). Little to no hair growth ...

Babies born during the pandemic’s first year—even to moms who did not have COVID during pregnancy—scored slightly lower on a screening test of social and motor skills compared to pre-pandemic babies.

Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.

A Columbia study addresses a key challenge in the diagnosis of rare genetic disorders.

Any time is a good time to take control of your financial well-being. On Tuesday, June 25, at noon, CU Thrive will host a financial wellness event for employees. Columbia experts will tackle topics ...